Delivery Order HHSN272201000019I-HHSN27200002
Award Date
9/5/13
Potential Completion Date
5/8/15
Potential Value
$122K
Federal Agency
NIAID DEA OA Acquisitions
Ultimate Awardee
Mount Sinai Hospital
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10029, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution in New York City. The contract, valued at $399,266.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to support the development of animal models of infectious diseases. The award is a delivery order under NIAID's larger "Animal Models of Infectious Diseases...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $42,132,619.00 definitive contract to the Icahn School of Medicine at Mount Sinai (ISMMS) for the NIAID Centers of Excellence for Influenza Research and Surveillance program. This cost-no-fee contract, awarded on March 30, 2007, has a performance period ending on May 23, 2017. ISMMS, a private university and non-profit organization, will...
This federal contract award to the Icahn School of Medicine at Mount Sinai (ISMMS) was made by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct research on "Modeling Immunity for Biodefense". The $17,219,467.21 cost-no-fee contract has a period of performance from September 30, 2010 to September 29, 2015 and does not have a set-aside designation. Under this award, ISMMS is collaborating with several subcontractors, including the California Institute of...
This federal contract award is for the "MODELING IMMUNITY FOR BIODEFENSE" program, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS), a private non-profit educational institution. The award is a $23,517,489.00 definitive contract with a cost-no-fee pricing type, with a period of performance from September 29, 2005 to September 29, 2010. The contract does not have a set-aside designation. ISMMS, a renowned...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private academic medical center and research institution located in New York, NY. The $18,691,713.00 cost-no-fee definitive contract is for biomedical research services, with a period of performance ending on March 31, 2011. The contract does not have a set-aside designation....
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private university and non-profit educational institution. The $10,799,605.00 Definitive Contract is for BIOMEDICAL (BASIC) services, with a Firm Fixed Price pricing type. The contract has no set-aside designation and was awarded on August 17, 2009, with a completion date of September...
This is a $128,680,006 federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the Icahn School of Medicine at Mount Sinai. The contract supports the NIAID Centers of Excellence for Influenza Research and Response (CEIRR) program, which aims to advance understanding of factors influencing influenza emergence and transmission, and develop pandemic response capabilities. The contract is a...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS) to support the Collaborative Influenza Vaccine Innovation Centers (CIVICS) program. The contract, valued at $150,567,831.64, will focus on designing and evaluating innovative influenza vaccine approaches based on principles of influenza immunity to achieve durable, robust protection. The award does not have a set-aside designation. Under...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract, worth a guaranteed minimum of $50,000.00, was awarded to the University of Massachusetts Medical School (UMass Medical) to provide animal models of infectious diseases research under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery vehicle (IDV). The contract is a firm...
This firm fixed price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to The Research Foundation for the State University of New York. The $832,888 contract is for the development of xenograft mouse models to study varicella zoster virus and human cytomegalovirus. This work is being performed under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery,...